INTRODUCTION
Adequate replacement of tissues and organs following injury or disease still remains a major challenge in medicine. Since the first cornea transplant in 1905, major advances have been made such that heart, lungs, kidneys, liver, pancreas, small bowel and bone marrow can now be transplanted. Although thousands of people benefit from receiving corneal and whole-organ transplants each year, the demand for organs is increasing worldwide. This is due, in part, to the increased incidence of diseases such as the pancreatic disorder diabetes. It is estimated that 150 million people worldwide currently suffer from diabetes mellitus and that number is predicted to rise to 300 million over the next 20 years [1] . Approximately 10-15 % are Type I diabetics, many of whom usually require insulin treatment for survival. The remainder are Type II diabetics, a proportion of whom may have a pancreatic pathology also requiring insulin treatment [2, 3] . Although insulin therapy is very successful, it does not constitute a cure, and diabetes continues to generate a substantial load of complications, in particular retinopathy, cardiovascular disease, neuropathy and nephropathy. Diabetic patients also consume a large and increasing proportion of both medical time and health-care budgets. Because of this, much research is directed towards methods of insulin delivery that can mimic the exquisite glucose-responsiveness of the normal pancreatic β-cell. Transplantation therapies for diabetes have been explored for many years, but islet cell transplants still involve serious problems of immune rejection and donor supply [4, 5] . Attempting to tackle the problem of diabetes would therefore require millions of donors. One way forward is to produce β-cells in vitro for transplantation (see below). An alternative approach is to use organs or tissue from a different species. Remarkably, xenografting has been applied for the treatment of some patients. For example, diabetic patients have been implanted with porcine islets and showed survival of grafted islets [6] with evidence of porcine c-peptide production. Similarly, patients with the kidney disease glomerulonephritis have been connected to whole porcine kidneys, although experiments were terminated due to tissue rejection and anaphylactic side effects [7] . In the last decade, advances in biomedical engineering have demonstrated the potential for the generation of bioartificial tissues and organs in vitro. This approach has two immediate benefits. Firstly, the artificial tissues can be used for transplantation. Secondly, the artificial organ could be used to maintain the patient in a viable state either until the affected organ regenerates (e.g. in some forms of liver failure) or until a donor becomes available. Furthermore, recent changes in our understanding of cell plasticity of both stem cells and differentiated cell types form the basis for the development of new cellular and gene therapy strategies. In this review, we will focus on the role of cellular plasticity in regeneration and tissue repair through a process termed transdifferentiation with particular emphasis on the liver and pancreas.
TRANSDIFFERENTIATION AND METAPLASIA

Definitions and criteria
The phenomenon of transdifferentiation is defined as the conversion of one differentiated cell type into another [8, 9] . Transdifferentiation belongs to a larger class of cell-type interconversions known as metaplasias, which include stem cell conversions. The term 'transdifferentiation' was first used to describe the conversion of cuticleproducing cells into salt-secreting cells in the silkmoth during metamorphosis from the larval to the adult moth [10] . Subsequently, Eguchi and Okada [11] described the switch of pigmented epithelial cells to lens fibres as 'transdifferentiation', a conversion that was elegantly demonstrated using an in vitro clonal cell culture system. In addition, Eguchi and Okada set the standard for determining whether a switch in cell type is a true transdifferentiation event by stating that the following criteria have to be met: firstly, a lineage relationship between the two cell types must be established, and secondly, any changes in cell morphology have to be accompanied by changes at the molecular level that will allow both cell types to be easily distinguished [12, 13] (Figure 1) .
It has been suggested in the theoretical work by Slack [14] that metaplasias occurring in man may represent homoeotic transformations that are more commonly observed in arthropods. Homoeotic transformations arise through the somatic mutation of homoeotic genes, normally required to distinguish between tissue rudiments, with the result that one body part is substituted for another. The best-characterized examples of such transformations are seen in the fruit fly Drosophila melanogaster. In the Antennapaedia mutant, a leg develops in the place of the antenna; however, the penetrance of such mutations has been manipulated in the laboratory to give a more dramatic phenotype. Naturally occurring transformations are more likely to involve small patches
Figure 1 Transdifferentiation of PECs to lens fibres during lens regeneration
PECs of the dorsal iris undergo depigmentation and re-entry into the cell cycle following lentectomy in the newt. Dedifferentiated epithelial cells redifferentiate to generate primary lens fibres expressing crystallins. Both criteria stated by Eguchi to define a true transdifferentiation are fulfilled by this conversion; the ancestor-descendent relationship can clearly be traced in vitro and both cell types are distinguishable morphologically and through the expression of cell-type specific markers.
of cells or tissue rather than whole segments. Based on this consideration, Slack [14, 15] proposed that there are indeed many examples of homoeosis in man, observed in the form of patches of epithelial tissue found in ectopic locations predominantly occurring in the gastrointestinal and reproductive tracts. Some of the best-documented examples of metaplasia (homoeosis) in man will be discussed below.
Why study transdifferentiation?
The phenomenon of transdifferentiation (or metaplasia) is important to study for a number of reasons. Firstly, studying transdifferentiation will tell us something about the normal developmental biology of the tissues that can convert in later life. Transdifferentiation normally occurs in tissues that arise from neighbouring regions of the developing embryo. This ability to interconvert suggests that the two tissues are related at the molecular level. What this means is that the tissues share some common transcription factors, but in addition there are one or two that are different. So overall, neighbouring tissues
Figure 2 Epithelial-mesenchymal transitions during nephrogenesis
Nephrogenesis begins with the condensation of metanephrogenic mesenchyme in response to signals from the uteric bud (A). The condensed mesenchyme becomes epithelial in nature generating the renal (epithelial) vesicle (B). Expansion of the renal vesicle through S-shaped and capillary loop stages gives rise to maturing podocytes which undergo a transition from epithelial to mesenchymal phenotype (C).
presumably differ in the expression of one or a few key transcription factors. The transcription factors that induce transdifferentiation are referred to as master switch (homoeotic) genes. If we can identify the genes that cause transdifferentiation, they might tell us something about the developmental differences that exist between adjacent regions of the embryo. Transdifferentiation is also important from the perspective of inducing stem cell differentiation. For example, if we can identify the gene(s) that induce the conversion of one cell type into an insulin-secreting pancreatic β-cell, it might be possible to overexpress this gene in a stem cell and induce β-cell differentiation. The resulting pancreatic β-cell could then be used for therapeutic transplantation into diabetic patients. Lastly, transdifferentiation is important to study for the purposes of identifying the molecular signals underlying tissue regeneration. In the future, it might be possible to promote regeneration in some tissues that do not normally regenerate.
Transdifferentiation/metaplasia in normal tissue
Transdifferentiation is typically associated with the diseased state or tissue damage and, consequently, there are few documented examples of transdifferentiation occurring in normal adult tissue. However, there are several examples of cell-type conversions that occur as a part of normal tissue development. The most commonly cited example of transdifferentiation during embryogenesis is the switch from smooth to skeletal muscle during oesophageal development [16] . Until recently, this was believed to be a transdifferentiation event. Using a transgenic approach that allowed permanent lineage tracing of smooth muscle cells with GFP (green fluorescent protein) and β-galactosidase, Rishniw et al. [17] suggested that, rather than transdifferentiating from smooth muscle cells, the skeletal myocytes originated from a discrete lineage. The discrepancy between these studies awaits further clarification.
Another example in which transdifferentiation may play a role is during kidney development. The metanephric mesenchyme is induced to generate the nephrons of the permanent kidney by signals emanating from the uteric bud. Nephrogenesis begins with the condensation of the metanephric mesenchyme to form an epithelial vesicle surrounded by a basement membrane. This is the first of a four-step process to generate mature glomeruli. The four stages are: the renal vesicle stage, the Sshaped (or comma-shaped) stage, the capillary loop stage and mature glomeruli stage (Figure 2 ). At the S-shaped phase, the glomerular epithelium is composed of simple cuboidal cells expressing cytokeratins and desmosomal proteins; these are the precursors to the highly specialized podocytes of the kidney. As the maturing podocytes enter the capillary loop stage, there is a concomitant loss of epithelial markers and a gain in expression of vimentin, the intermediate filament marker characteristic of mesenchymal cells. It has been suggested that this switch represents the transdifferentiation of an epithelial into a mesenchymal phenotype [18] . However, it should be noted here that occasionally, a cell-type conversion arising during development is referred to as transdetermination, which is the switch of a cell from one state of determination to another.
Clinical importance of metaplasia
Metaplasia has two important clinical implications. The first is that some metaplastic changes, such as those seen in Barrett's metaplasia and intestinal metaplasia of the stomach (see below), predispose an individual to progress to a neoplastic state. Secondly, metaplasia (or transdifferentiation) provides an alternative method for the development of cell-based therapies. The latter will be discussed in more detail later in relation to the treatment of conditions such as diabetes and liver dysfunction.
Barrett's metaplasia, sometimes referred to as Barrett's oesophagus, is one of the best documented examples of epithelial transformation in man. It is believed that Barrett's metaplasia arises as a progression from oesophagitis in around 10 % of individuals affected by gastro-oesophageal reflux disease [19] . Barrett's metaplasia carries an increased risk (30-125-fold) of developing oesophageal and gastro-adenocarcinoma, a neoplastic condition with a poor prognosis [20] . Histologically, Barrett's metaplasia is characterized by the presence of intestinal-type tissue in place of the stratified squamous epithelia that normally lines the oesophagus. The exact origin of metaplastic tissue in Barrett's oesophagus is uncertain but, given that the turnover rate of gastrointestinal cells is 3-10 days, with the exception of stem cells, it is unlikely that these cells contribute to the development of neoplasia. There are currently three theories suggesting the potential origins of Barrett's metaplasia. Firstly, damaged stem cells in the squamous tissue may undergo a phenotypic alteration to produce Barrett's stem cells that will subsequently give rise to intestinal-type tissue [19] . Secondly, cells located at the gastro-oesophageal junction or transitional zone exhibit remarkable pluripotency and, if these cells colonize the distal oesophagus, they may give rise to columnar-type tissue in response to oesophageal injury [21] . The third theory suggests that during mucosal damage the oesophagus may be colonized by stem cells that normally reside in the ducts of the glandular-neck region [22] .
Another example of metaplasia is the appearance of intestinal-type tissue in the stomach. Intestinal metaplasia is believed by clinicians to be a premalignancy to gastric carcinoma. In normal gastric mucosa the glands arise as tubular extensions from epithelial invaginations termed pits. Gastric stem cells are located at the junction between the pit and the gland, a region called the isthmus, from which the different cell types of the stomach originate. Parietal, enteroendocrine and caveolated cells migrate in both directions while enzyme-producing zymogenic cells migrate down into the gland and mucus-producing pit cells migrate towards the surface [23] . Intestinal stem cells are located at the base of the crypts of Lieberkühn and give rise to progenitors that will differentiate into secretory cells, such as enteroendocrine, goblet and Paneth cells, or cells that will become absorptive enterocytes. Differentiation of all cell lineages, with the exception of Paneth cells, which differentiate at the base of the crypt where they will remain, takes place as the progenitors migrate out of the crypt towards the tip of the villi [24] . Intestinal metaplasia is characterized by the presence of ectopic intestinal tissue within the gastric mucosa, and can be subdivided into two types; 'complete' or type I intestinal metaplasia and 'incomplete' comprising type II and type III intestinal metaplasia. As the name suggests, ectopic tissue found in 'complete' intestinal metaplasia contains absorptive, Paneth and goblet cells all of which are typically found in the small intestine, whereas only columnar and goblet cells are present in 'incomplete' intestinal metaplasia. Epidemiological studies have revealed that the greatest risk of developing gastric cancer is associated with type III intestinal metaplasia [25, 26] . As with Barrett's metaplasia, the cells contributing to these metaplastic changes are believed to be the stem cells, which are susceptible to genetic alteration under conditions of inflammation or infection [27] . Interestingly, expression of the caudal-related homeobox transcription factors Cdx1 and Cdx2 has been localized to intestinal metaplastic tissue of the human stomach, suggesting that ectopic expression of these genes may contribute to the mechanism underlying intestinal metaplasia [28, 29] . Both Cdx1 and Cdx2 are essential for the development, differentiation and maintenance of intestinal cell fate and their expression is restricted to the epithelial layers of the small intestine and colon during the later stages of mammalian development and in adult tissues. The potential role for the Cdx genes in intestinal metaplasia is supported further by the transgenic studies of two independent groups in which mice mis-expressing Cdx2 under the control of stomach-specific promoters develop lesions containing intestinal-type tissue within the gastric mucosa [30, 31] . Additional mouse studies demonstrate the role for Cdx2 in the maintenance of the intestinal phenotype. Mice expressing only one allele for Cdx2 develop lesions containing fore-stomach epithelia (negative for Cdx2) in more posterior gut structures such as the terminal ileum and proximal colon. Remarkably, in these animals, intercalary (or epimorphic) regeneration of tissue types occurs between the surrounding colonic mucosa and the ectopic gastric tissue, constituting the first known example of this type of regeneration in mammals [32] .
Other examples of metaplasia occurring in disease include liver fibrosis [33] . Hepatic stellate cells (also known as fat-storing Ito cells, perisinusoidal lipocytes or vitamin A-storing cells) are responsible for the synthesis and degradation of ECMs (extracellular matrix components) in the liver. In response to injury, stellate cells become activated by mitogens released from damaged hepatocytes and undergo a change (or transdifferentiation) from a normally quiescent vitamin A-rich cell type to a more fibroblastic cell type termed MFBs (myofibroblasts). Subsequent MFB proliferation leads to the accumulation of an ECM rich in type I collagen, the infiltration of inflammatory cells and the development of fibrotic tissue typically seen in cirrhosis [34] . Understanding the steps leading to the development of metaplasia may help to identify early markers, e.g. in the progression to a neoplastic state, or provide targets for therapeutic intervention.
TRANSDIFFERENTIATION IN REGENERATION AND TISSUE REPAIR
Regeneration of whole tissue and organs
The ability to regenerate cells and tissues is possessed by all organisms. However, regenerative capacity varies considerably between species. As a general rule of thumb, the extent to which tissues can be replaced diminishes as the species ladder is climbed. The mechanisms mediating regeneration may be quite basic, such as axonal outgrowth of severed nerves, or a more complex process that involves dedifferentiation, proliferation and transdifferentiation which is typically seen in amphibians. The urodele amphibians provide some of the most striking examples of tissue regeneration, exhibiting the ability to regenerate lens, retina, jaw, and limb and tail structures. We will examine a few examples here.
Lens and retina
One of the best characterized examples of regeneration of whole new tissues/organs following damage or experimental removal is seen in the adult newt [35, 36] . Lens regeneration in the newt depends entirely upon the transdifferentiation of PECs (pigmented epithelial cells) arising from the dorsal iris. Following lentectomy, PECs begin to dedifferentiate, losing expression of specific markers such as MMP115, tyrosinase and TRP-1 to become unspecified progenitor-like cells. Within 10 days of lentectomy, the dedifferentiated PECs form a new lens vesicle in the region of the dorsal iris and the synthesis of crystallins marks the beginning of primary lens fibre differentiation ( Figure 1 ). As secondary lens fibres appear, PEC depigmentation and proliferation declines and regeneration of a whole new lens is complete 25-30 days following lentectomy [37, 38] . Although the mechanism underlying transdifferentiation of PECs to lens fibres is not fully understood, it has been shown that thrombin, a serine protease involved in the clotting cascade, is absolutely required for PECs to re-enter the cell cycle [39] . Thrombin is specifically activated in the dorsal iris, but not in the ventral iris, and nor is it activated in the iris of species that cannot regenerate the lens (e.g. salamanders). It has been proposed that thrombin promotes dedifferentiation and proliferation of PECs through the activation of a still unknown serum factor [40] .
Transdifferentiation is also the process via which lens regeneration occurs in the frog. However, lens fibres transdifferentiate from cells arising from the inner layer of the outer cornea, but this conversion can only take place prior to morphogenesis [41] . Several genes, including those encoding FGFR1 (fibroblast growth factor receptor 1), RAR (retinoic acid receptor) and the transcription factors Pax6 and Prox1, have been shown to be expressed in both the developing and regenerating lens [42] [43] [44] [45] . There is strong evidence to suggest that, of these genes, FGFR1 may play an essential role in mediating the transdifferentiation events that occur during lens regeneration. Both newt PECs and frog outer cornea transdifferentiate in vitro when cultured in the presence of FGF1; furthermore, lens regeneration in vivo is prevented by the FGFR1-specific inhibitor SU5402 [46, 47] .
Regeneration of retinal tissue has been observed in several species and is brought about through stem cell differentiation as well as transdifferentiation. However, the ability to regenerate the retina entirely through transdifferentiation in adult life is restricted to certain urodeles and begins with the gradual depigmentation of rPECs (retinal PECs) and their detachment from the basement membrane [38] . The transdifferentiating rPECs adopt a transitional state during which time they possess both rPEC and neuronal cell properties. Eventually a neuroepithelial layer of cells is generated which can differentiate to produce all retinal cell types in a process similar to retinal development from the neural retina during embryogenesis [48] . Although there is some evidence to suggest that FGF2, laminin and heparin sulphate proteoglycans may play a role in mediating the transdifferentiation of rPECs to neuroepithelial cells, as in lens regeneration, the underlying molecular mechanisms have not yet been fully characterized [49] [50] [51] . Understanding these mechanisms may lead to the development of therapies for the replacement or repair of damaged lens or retinal tissue in humans.
Limb and tail
The ability of some species of amphibians to regenerate appendages following amputation was first reported in 1768 by Spallazani (reviewed in [52] ). Following amputation of a limb, the stump becomes covered by a sheet of epithelial cells which form the wound epidermis. Beneath this epidermis the muscle, cartilage and connective tissue dedifferentiate to become progenitor-like cells, known as blastemal cells, that will later give rise to all the different components of the regenerating appendage (skin, muscle, cartilage and bone) [53] . Therefore, by definition, blastemal cells are undifferentiated epithelial cells. Cell-tracking experiments in which rhodamine-dextran labelled myotubes were transplanted into newt limbs demonstrated that limb regeneration also involves transdifferentiation [54] . Although these transdifferentiation events are infrequent, Lo et al. [54] showed that, 1 week following transplantation of the labelled myotubes, the blastema was found to contain labelled mononucleated cells. Subsequently, these cells underwent a switch in phenotype, redifferentiating to contribute to both muscle and cartilage components of the regenerating limb.
Amputation of the tail in urodele amphibians also elicits a response in which an exact replica of the tail, containing all the normal components (skin, muscle, cartilage and spinal cord) will be regenerated. Utilizing a GFP reporter driven by the GFAP (glial acidic fibrillary protein) promoter to mark glial cells, Echeverri and Tanaka [55] elegantly demonstrated that, during tail regeneration, muscle, chondrocytes and neurons could be generated from neural cells (either ependymal or radial glial cells) originating from the spinal cord. This example of regeneration is particularly striking because cells of ectodermal origin can give rise to both ectodermal (neurons) and mesodermal (muscle) cell types. However, a recent lineage tracing study by Slack et al. [56] showed that this phenomenon does not occur in other vertebrates. During regeneration of Xenopus laevis tail following amputation, the cells of the spinal cord and notochord regenerate from the same tissue in the stump. These observations raise the question as to why this type of regeneration does not occur in mammals. Interestingly, there is some evidence in the literature that both mice and humans can regenerate digit tips [57] . Mice regenerate foretoes when amputated distally to the last interphalangeal joint, but more extensive damage did not result in digit replacement. Similarly, Illingworth [58] observed that fingertips accidentally severed in young children could re-grow perfectly within 3-4 months. Comparing the differences between regenerative and non-regenerative species may eventually lead to the development of therapies for the replacement or repair of severely damaged tissue in humans.
Tissue regeneration in mammals
The ability for tissue regeneration in mammals is generally considered to be significantly reduced compared with lower vertebrates. Some tissues, such as the epithelia of the gastrointestinal tract and the skin, exhibit a high capacity for regeneration which allows for rapid replacement and repair as part of the normal process of tissue maintenance. The cells of the gastric and intestinal epithelia are constantly exposed to mechanical and chemical stresses that result in damage and cell loss. Consequently, there is a rapid turnover and replacement of cells through the generation of new epithelial cell types every 2-7 days from the respective gastric and intestinal stem cell compartments. In contrast, some tissues, such as the liver, are more stable with very low turnover rates of less than 1 in 20 000 hepatocytes undergoing cell division at any one time [59] . However, the liver is one of very few organs that exhibit a remarkable capacity for regeneration even after removal of up to 70 % of functional tissue mass. The best characterized examples of tissue regeneration in mammals are seen in the liver and pancreas, although the modes of tissue replacement largely depend upon proliferation of remaining cells and recruitment of tissue-specific stem cells.
Liver
Many animal models have been developed to demonstrate hepatic regeneration in vivo and the mode of regeneration varies depending on the cause of liver damage. For example, the best documented case of tissue regeneration in the liver comes from studies in which rats were subjected to two-thirds hepatectomy [60] [61] [62] [63] or treatment with the hepatotoxin CCl 4 (carbon tetrachloride) [64, 65] . In both cases, regeneration of hepatic tissue is brought about through the proliferation of existing mature hepatocytes with no evidence of activation of a hepatic progenitor population. Despite the normally low proliferative rate of hepatocytes, these cells can replicate sufficiently to maintain basic metabolic functions even after extensive cell or tissue loss [66, 67] . However, it is still unknown how other liver cell types such as cholangiocytes and stellate cells are regenerated in these experimental models. The molecular mechanisms mediating the regenerative response following PH (partial hepatectomy) or CCl 4 treatment are not fully characterized but involve increased release of the cytokines TNFα (tumour necrosis factor α) and IL-6 (interleukin-6) [68] which, in turn, leads to the changes in the expression of the transcription factors NFκB (nuclear factor-κB) [69] , STAT3 (signal transducer of transcription 3) [70] , C/EBPα and C/EBPβ (where C/EBP is CCAAT/enhancer-binding protein) [71] . Liver regeneration, under certain conditions, may also occur through the activation of the liver stem cell compartment believed to reside in the canals of Hering. Oval cells (so-called because of their oval nuclei) are considered to be the progenitors of stem cells. They are thought to be bipotential, i.e. can generate both hepatocytes and biliary epithelial cells. Oval cells derived from the small bile ductules were first identified in the liver of rats treated with the azo-dye 'butter yellow' [72] . Normally quiescent and not easily detected in the normal liver, oval cells undergo abundant proliferation in many models of hepatic injury induced by hepatotoxins or carcinogens. For example treatment of rodents with d-galactosamine [73, 74] , AAF (2-acetyl aminofluorene) [75] and dipin [76] results in activation of oval cells and regeneration of both hepatocytes and biliary epithelial cells. Interestingly, with the exception of the possible contribution of bone marrow-derived stem cells (although this is controversial), metaplasia does not appear to contribute to the normal regeneration of the liver.
Pancreas
The pancreas possesses a surprising capacity for regeneration. Bonner-Weir and co-workers [77, 78] studied pancreatectomy in rats as a model for diabetes and demonstrated that within 8-10 weeks following 90 % removal of the pancreas there was considerable regeneration of both functional exocrine and endocrine tissue. Several growth factors and related peptides have been shown to be involved in pancreatic regeneration following pancreatectomy and may act by promoting islet neogenesis. The factors include CCK-A (cholecystokinin-A) [79] , IGF-1 (insulin-like growth factor-1) [80] , exendin-4 [81] and the protein Reg I [82] . A role for IFN-γ (interferon-γ ) has also been demonstrated using a transgenic approach in which the IFN-γ gene was expressed in pancreatic β-cells under the control of the insulin promoter [83] . In this model, pancreatic inflammation leads to islet destruction reminiscent of Type I diabetes. However, IFN-γ transgenic mice also exhibit rapid regeneration of islets through the proliferation and differentiation of duct cells, a process involving the transcription factors Msx-2, Pax-4, Pax-6, Pdx-1 and Isl-1 [84, 85] . The involvement in pancreatic regeneration of transcription factors required for the generation of endocrine cells during development suggests that both these processes are very similar at the molecular level. Therefore studying developmental processes involved in generating specific organs may provide insight into the pathways mediating regeneration of those organs in later life.
TRANSDIFFERENTIATION OF LIVER AND PANCREAS
Although there are few (if any) examples of transdifferentiation events that occur during normal liver and pancreas regeneration, there are many documented cases of experimental and clinical conditions in which transdifferentiation arises within these tissues. Usually these transdifferentiation events give rise to the formation of tissue found in other endodermally derived organs. For example, 'intestinal-type' metaplastic glands, containing Paneth, goblet and neuroendocrine cells typically found in the intestine, form in the liver of rats treated with the cholangiocarcinogen furan [86, 87] . However, some of the best-documented examples of transdifferentiation are observed in the conversion of pancreatic cells into hepatocytes and to a lesser extent the conversion of hepatic into pancreatic tissue.
Pancreas to liver transdifferentiation
Perhaps one of the best-characterized examples of hepatic transdifferentiation in the pancreas is the copper-deficient protocol developed by Reddy and co-workers [88] . In this model, rats were fed a copper-deficient diet along with the copper-chelating agent triethylenetetramine tetrahydrachloride. After 7-9 weeks, the rats were returned to a normal diet. Subsequently, during the 6-8 week recovery period more than 60 % of the pancreatic volume was occupied by albumin-expressing hepatocytes. Under these experimental conditions there is extensive destruction of pancreatic acinar cells, which was associated with the proliferation of both ductular epithelial cells and oval cells. Although the mechanism is not known, it is believed that these cells transdifferentiate to form hepatocytes. Another model describes the conversion of regenerating pancreatic cells into hepatocytes in the Syrian golden hamster following a single dose of the carcinogen N-nitrosobis(2-oxopropyl)amine [89] . It is believed that the carcinogen binds to the DNA of mitotic cells and in doing so alters gene expression such that the cells undergo a phenotypic alteration. There are other examples of pancreatic to hepatic transdifferentiation, including the appearance of hepatic foci in transgenic mice overexpressing KGF (keratinocyte growth factor) from the insulin promoter [90] , following transplantation of a cell population enriched for pancreatic epithelial progenitors into the rat liver [91] and as a naturally occurring phenomenon in the vervet monkey and in human pancreatic tumours [92, 93] . The in vivo models for the transdifferentiation of pancreas to liver, particularly the copperdepletion-repletion model, have been extremely valuable in demonstrating the potential for conversion of pancreas into liver. However, determining the cellular and molecular mechanisms underlying conversion of pancreatic cells into hepatocytes is difficult to dissect from the in vivo studies. To address this problem, we developed an in vitro model for the transdifferentiation of pancreatic cells to hepatocytes [94] (Figure 3) . The pancreatic tumour cell line AR42J was originally isolated from an azaserine-treated rat [95, 96] . AR42J cells exhibit amphicrine properties expressing characteristics of both exocrine (e.g. amylase) and neuroendocrine (e.g. neurofilament) phenotypes [95, 96] . AR42J cells display a degree of plasticity upon treatment with a variety of growth factors and hormones. The exocrine phenotype of these cells is enhanced by short-term (48 h) culture with dexamethasone, whereas longer exposure leads to their conversion into hepatocytes [94, 95, [97] [98] [99] [100] [101] . AR42J cells can also be induced to produce insulin-secreting β-cells in the presence of activin and HGF (hepatocyte growth factor) or betacellulin, whereas the addition of GLP-1 (glucagonlike peptide-1) to AR42J cells gives rise to both insulinand glucagon-expressing cells [102] [103] [104] . The plasticity possessed by the AR42J cell line makes it a good model for pancreatic stem cells and a potentially interesting system to study transdifferentiation to liver. Converting pancreatic cells into hepatocytes also offers an alternative method for producing long-term hepatocyte cultures as an in vitro model for studying liver function as these cells exhibit many of the properties of differentiated hepatocytes [98, 100] . It will be important to determine: (i) whether these cells are truly functional, ultimately by rescuing an animal model of liver disease, and (ii) whether human pancreatic cells can also transdifferentiate to hepatocytes.
Liver to pancreas transdifferentiation
The appearance of pancreatic tissue in the liver has also been reported under both naturally occurring and experimental circumstances. Pancreatic heterotopia (heterotopia comes from the Greek words 'heteros' meaning 'other' and 'topos' meaning 'place') may be characterized by the presence of both exocrine and/or endocrine tissue in an ectopic location. However, of all documented cases, only 0.5 % exhibit a hepatic location and only one example of intrahepatic pancreatic heterotopia describes the presence of endocrine cells [105] [106] [107] [108] . The appearance of exocrine tissue in the liver is often associated with hepatic injury or tumours. Why there is a difference in the potential to induce exocrine and endocrine cell types in the liver remains elusive. Pancreatic-type tissue has also been found to occur in the livers of rats treated with polychlorinated biphenyls and in fish exposed to chemical carcinogens such as diethylnitrosamine, aflatoxin B 1 or cyclopropenoid fatty acid [109] [110] [111] [112] [113] .
Recently several independent groups have demonstrated the conversion of hepatic into pancreatic tissue using transgenic animal models. In a study using Hes1 knockout mice, Sumazaki and co-workers [114] demonstrated the conversion of the developing biliary system into pancreatic tissue possessing both exocrine tissue and the full complement endocrine cell types α-(glucagon), β-(insulin), δ-(somastostatin) and PP (pancreatic polypeptide) cells [114, 115] . However, as the developing liver is not fully differentiated, the presence of ectopic pancreas in the Hes1 knockout mice may represent an example of transdetermination. A similar switch in phenotype was observed by Horb and co-workers [116] . In this example, human hepatoma cells and transgenic tadpoles expressed an activated form of Pdx1 (pancreatic and duodenal homeobox 1) in the liver. As a result of transgene expression, liver cells were converted into both exocrine and endocrine cell types [116] . Pdx-1 is an essential transcription factor involved in pancreas development and is restricted to β-cells of the adult pancreas where it can bind to the insulin promoter [117, 118] . The importance of Pdx1 in pancreatic function has been demonstrated by the specific inactivation of the pdx1 gene in β-cells of adult mice with the resulting loss of insulin-producing cells followed by development of Type II (maturity onset) diabetes [119] . Using a gene therapy approach, adenoviral delivery of Pdx1 to adult mice has also been shown to induce sufficient synthesis of insulin to alleviate hyperglycaemia induced by streptozotocin [120] . 
TISSUE ENGINEERING OF LIVER
There has been much interest in recent years in using stem cells to repair or regenerate damaged tissues and organs. Stem cells can be utilized as a source for cell transplantation due to their ability to differentiate into a variety of cell types (Figure 4 ). Stem cells, either embryonic (derived from the inner cell mass of the blastocyst [121] ) or liver stem cells [122, 123] , are a potential source of hepatocytes either for transplantation or for an artificial liver system.
Tissue engineering is defined as the application of engineering principles for the purposes of generating a threedimensional structure that is functionally equivalent to the original tissue. It is part of the emerging field of regenerative medicine in which the regeneration of damaged or defective tissues is stimulated. However, replacement of diseased or damaged organs constitutes one of the fundamental challenges to tissue engineers.
In order to achieve the goal of tissue engineering, a number of criteria must be considered. These include: (i) a source of cells; (ii) generation of sufficient numbers of cells; (iii) maintenance of the differentiated phenotype; and (iv) production of a three-dimensional organization. Ideally, cells for liver therapies should expand extensively in vitro, differentiate into mature liver cells, have minimal immunogenicity and be able to reconstitute liver tissue when transplanted in vivo.
The bioartificial liver is one development that may prove useful in the treatment of patients with liver failure.
At present, the systems consist of either immortalized human cells or porcine hepatocytes contained within a membrane through which the patient's blood is circulated over a period of several hours [124] [125] [126] . Designing a smaller transplantable device would eliminate the need for long treatment times and allow better homoeostatic control.
Recapitulating liver function in vitro is difficult. Unfortunately, a major limitation to the use of primary hepatocytes in such cases is the rapid and irreversible loss of differentiated functions in culture. The loss of differentiated phenotype is most apparent in the rapid decline of total CYPs (cytochrome Ps) after isolation and in culture, particularly the CYP3A1 isoform [127] . Dedifferentiation is reflected not only in decreased liver-specific functions, but also in an alteration of morphology: the cells flatten, depolarize and lose many of the surface characteristics of normal hepatocytes in vivo. The mechanisms responsible for loss of differentiated properties include down-regulation of transcription factors [e.g. C/EBPα and HNF1 (hepatocyte nuclear factor 1)] involved in liver-specific gene expression and a switch from a quiescent to a proliferative mode [127] . The loss of differentiated functions has been attributed to the change in environmental conditions (extracellular matrix and hormonal conditions) following cell isolation. Conventional approaches to maintaining the differentiated properties of isolated hepatocytes in culture include supplementation of the medium with hormones [128, 129] , co-factors such as nicotinamide, pyruvate, DMSO and phenobarbital [130, 131] , the application of extracellular matrix components [132] [133] [134] , and co-culture with non-parenchymal epithelial cell-types [135] [136] [137] [138] . A number of alternatives have been used, including isolated established liver cell lines (e.g. HepG2 and Hep3B), but these lack the urea cycle enzymes. Although these systems have both advantages and disadvantages, there is no system currently available which satisfies the requirements (expression of numerous liver genes and maintenance of liver gene expression). Transdifferentiated hepatocytes may therefore offer an alternative approach compared to conventional hepatocyte preparations.
CONTROVERSIES SURROUNDING TRANSDIFFERENTIATION
There has been much interest in recent years in using stem cells to repair or regenerate damaged tissues and organs. The stem cells might be embryonic stem cells obtained from embryos, or they might be 'adult stem cells', which are the cells responsible for the normal turnover of tissues in the body. Most tissue types probably contain stem cells, but the most accessible ones lie in the bone marrow. Marrow transplantation has been for some time a routine technique used in cancer chemotherapy and other situations [139] . Human bone marrow can be obtained from living donors, and either autologous or allogeneic transplantation is possible. Autologous transplantation obviously has the advantage of avoiding graft rejection by the host, and graft-versus-host disease carried by the T-cells of the graft. In the last few years, there have been numerous reports of the colonization of a large range of tissue types after transplantation of bone marrow from one animal to another [8, 9, 140] . This has been a controversial area and some results have been hard to replicate, whereas others have been shown to be due to cell fusion [123, 141] . However, there is a residue of well-controlled studies that show clearly that bone marrow-derived cells can colonize a wide variety of tissues in the body of a host without cell fusion [142, 143] . Although derived from the embryonic mesoderm, the developmental potential of bone marrow cells is not restricted to this germ layer and they have been shown many times to populate tissues of ectodermal and endodermal origin [144, 145] . It therefore appears that bone marrow represents a possible source of pluripotent cells which might be deployed for tissue or organ repair. However, the reported frequencies of colonization are low, and it is unlikely that there is much repair of organ damage by bone marrow in the normal individual or it would be happening all the time spontaneously. Therefore, for future therapeutic applications, there is a need for reliable methods to control differentiation of the relevant bone marrow cell populations. How this will be achieved is difficult to know; perhaps by growth on suitable extracellular matrices, addition of soluble factors or by genetic reprogramming in vitro. Towards this end, transient reprogramming of myofibroblasts towards a β-cell phenotype has been demonstrated [146] . Exposure of permeabilized myofibroblasts to extracts isolated from insulinoma cells was sufficient to cause expression of the pancreatic markers Pdx-1 and insulin for up to 4 weeks, indicating that such techniques have enormous potential in the development of cellular therapies.
SUMMARY
Transdifferentiation has been shown to occur in a wide variety of animal model systems. In addition, there are some human cases of bone marrow transplantation that suggest metaplasia is occurring under certain circumstances. However, the real future for transdifferentiation research lies in curing human disorders. The ability to take one cell type from a patient and convert it into another cell type for the treatment of that individual will not only eliminate the requirement for donor tissue which is in limited supply, but may also overcome the problems associated with immunological tissue rejection. Although this is not attainable at the moment, current and future work investigating the mechanisms underpinning transdifferentiation may eventually lead to the development of therapeutic strategies for cell replacement.
